Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Encaleret by BridgeBio Pharma for Autosomal Dominant Hypocalcemia: Likelihood of Approval
Encaleret is under clinical development by BridgeBio Pharma and currently in Phase III for Autosomal Dominant Hypocalcemia. According to GlobalData,...